Not Rated
|
Fund Size
(0.02% of Investment in Category)
|
Expense Ratio
(2.12% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 24-Oct-25 | 9916.70 | -0.83% | - | 0.28% | 221/236 |
| 1 Month | 30-Sep-25 | 10327.70 | 3.28% | - | 3.65% | 140/238 |
| 3 Month | 31-Jul-25 | 9715.00 | -2.85% | - | 3.41% | 231/235 |
| 6 Month | 30-Apr-25 | 10177.30 | 1.77% | - | 9.90% | 218/224 |
| YTD | 01-Jan-25 | 9446.30 | -5.54% | - | 4.30% | 197/212 |
| 1 Year | 31-Oct-24 | 9731.60 | -2.68% | -2.68% | 4.01% | 163/196 |
| 2 Year | 31-Oct-23 | 14929.40 | 49.29% | 22.15% | 21.12% | 66/151 |
| Since Inception | 14-Dec-22 | 16837.10 | 68.37% | 19.81% | 12.64% | 39/217 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 31-Oct-24 | 12000 | 12185.69 | 1.55 % | 2.87 % |
| 2 Year | 31-Oct-23 | 24000 | 26253.2 | 9.39 % | 8.86 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 190.3 | 21.61% | -0.35% | 25.51% (Apr 2025) | 21.61% (Sep 2025) | 1.19 L | -3.39 k |
| Cipla Ltd. | Pharmaceuticals | 95.8 | 10.88% | -0.55% | 11.42% (Aug 2025) | 10.2% (Dec 2024) | 63.72 k | -0.33 k |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 84.5 | 9.59% | -0.21% | 10.28% (Dec 2024) | 9.23% (Mar 2025) | 69.02 k | -0.32 k |
| Divis Laboratories Ltd. | Pharmaceuticals | 81.9 | 9.30% | -0.65% | 11.01% (May 2025) | 9.3% (Sep 2025) | 14.39 k | -70.00 |
| Lupin Ltd. | Pharmaceuticals | 52.4 | 5.95% | 0.09% | 6.89% (Dec 2024) | 5.7% (Jul 2025) | 27.41 k | -0.13 k |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 42.7 | 4.85% | 0.09% | 4.85% (Sep 2025) | 3.73% (Oct 2024) | 11.85 k | -60.00 |
| Laurus Labs Ltd. | Pharmaceuticals | 37.1 | 4.21% | -0.08% | 4.29% (Aug 2025) | 2.44% (Oct 2024) | 44.01 k | -0.55 k |
| Alkem Laboratories Ltd. | Pharmaceuticals | 34.6 | 3.93% | 0.28% | 3.93% (Sep 2025) | 3.31% (Jul 2025) | 6.38 k | 254.00 |
| Aurobindo Pharma Ltd. | Pharmaceuticals | 34.3 | 3.90% | 0.23% | 4.92% (Oct 2024) | 3.67% (Aug 2025) | 31.68 k | -0.16 k |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 33.3 | 3.78% | 0.08% | 3.93% (Jul 2025) | 2.69% (Apr 2025) | 17.06 k | -86.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.87% |
| Net Receivables | Net Receivables | -0.82% |
Ratios calculated on daily returns for last 3 years (Updated as on 30th September, 2025)
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Regular Plan - Growth | NA | 406.67 | 6.62 | 28.01 | 80.06 | 50.55 | 43.10 |
| Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth | NA | 266.19 | 2.16 | 8.35 | 24.57 | 33.52 | 17.77 |
| Franklin Asian Equity Fund - Growth | NA | 279.13 | 5.37 | 12.02 | 27.45 | 22.75 | 18.53 |
| Nippon India Japan Equity Fund - Growth | NA | 289.73 | 1.07 | 7.80 | 15.92 | 21.76 | 18.97 |
| HDFC Transportation and Logistics Fund - Regular Plan - Growth | NA | 1651.55 | 2.23 | 11.29 | 28.68 | 20.88 | 0.00 |
| DSP Banking & Financial Services Fund - Regular Plan - Growth | NA | 1419.62 | 4.40 | 5.33 | 9.76 | 16.28 | 0.00 |
| Quant BFSI Fund - Regular Plan - Growth | NA | 655.17 | 3.05 | 3.93 | 18.38 | 16.26 | 0.00 |
| Nippon India US Equity Opportunities Fund - Growth | NA | 724.35 | 1.13 | 4.50 | 16.89 | 16.15 | 20.24 |
| SBI Banking & Financial Services Fund - Regular Plan - Growth | NA | 8693.07 | 4.37 | 5.08 | 9.78 | 15.37 | 19.02 |
| ITI Banking and Financial Services Fund - Regular Plan - Growth | NA | 311.03 | 6.24 | 5.30 | 7.73 | 15.15 | 13.55 |
Out of 174 mutual fund schemes offered by this AMC, 10 is/are ranked 5 * , 8 is/are ranked 4 * , 15 is/are ranked 3 * , 5 is/are ranked 2 * , 2 is/are ranked 1 * , and 134 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| ICICI Prudential Large Cap Fund - Growth | 5 | 73034.52 | 3.59 | 3.57 | 6.66 | 7.10 | 17.82 |
| ICICI Prudential Multi-Asset Fund - Growth | 3 | 67999.63 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| ICICI Prudential Multi-Asset Fund - Growth | 3 | 67999.63 | 3.74 | 6.87 | 9.61 | 13.65 | 19.93 |
| ICICI Prudential Balanced Advantage Fund - Growth | 2 | 66750.51 | 2.14 | 3.62 | 6.73 | 9.78 | 13.22 |
| ICICI Prudential Value Fund - Growth | 5 | 55444.54 | 5.15 | 5.17 | 8.66 | 8.88 | 21.80 |
| ICICI Prudential Equity & Debt Fund - Growth | 5 | 46392.05 | 2.57 | 4.25 | 7.00 | 9.36 | 19.14 |
| ICICI Prudential Liquid Fund - Growth | 3 | 45629.29 | 0.47 | 1.41 | 2.98 | 6.66 | 6.97 |
| ICICI Prudential Money Market Fund - Growth | 4 | 34019.73 | 0.50 | 1.44 | 3.35 | 7.63 | 7.56 |
| ICICI Prudential Corporate Bond Fund - Growth | 3 | 33753.23 | 0.81 | 1.47 | 3.35 | 8.29 | 7.92 |
| ICICI Prudential Equity - Arbitrage Fund - Growth | 4 | 32573.00 | 0.49 | 1.24 | 2.71 | 6.49 | 7.03 |